2-DEOXY-4-O-(3-DEOXY-4-C-METHYL-3-(METHYLAMINO)-.BETA.-L-ARABINOPYRANOSYL)-6-O-(2,6-DIAMINO-2,6-DIDEOXY-.ALPHA.-D-GLUCO-HEXOPYRANOSYL)-L-STREPTAMINE
UNII 4335L1O09Y
Substance Identification & Data
This profile provides standardized clinical and technical data for 2-deoxy-4-o-(3-deoxy-4-c-methyl-3-(methylamino)-.beta.-l-arabinopyranosyl)-6-o-(2,6-diamino-2,6-dideoxy-.alpha.-d-gluco-hexopyranosyl)-l-streptamine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 4335L1O09Y.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C19H39N5O9 YQGZDAPJXRYYLX-IHJSXESISA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 2-deoxy-4-o-(3-deoxy-4-c-methyl-3-(methylamino)-.beta.-l-arabinopyranosyl)-6-o-(2,6-diamino-2,6-dideoxy-.alpha.-d-gluco-hexopyranosyl)-l-streptamine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.